Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents.

Faculty of Pharmacy

Assiut University

Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents.

Research Authors
Tarek Aboul-Fadl, Wael M. El-Sayed, Tenley Schofield, Jonathan Constance, John G. Lamb, Jeanette C. Roberts, and Michael R. Franklin.
Research Department
Department of Medicinal Chemistry
Research Journal
229th ACS National Meeting, San Diego, California, USA, March 13-17, 2005.
Research Publisher
ACS
Research Rank
3
Research Year
2005
Research Member
Tarek Aboul-Fadl Mohammad Hassan